These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12174910)

  • 1. Transforming growth factor beta type II receptor expression in gastric cancer: evidence for two independent subgroups.
    Takeno S; Wirtz HC; Lickvers K; Noguchi T; Scheven M; Willers R; Gabbert HE; Mueller W
    Anticancer Res; 2002; 22(4):2247-52. PubMed ID: 12174910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
    Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
    J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominant cytosolic localization of type II transforming growth factor beta receptors in human breast carcinoma cells.
    Koli KM; Arteaga CL
    Cancer Res; 1997 Mar; 57(5):970-7. PubMed ID: 9041203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers.
    Takenoshita S; Tani M; Nagashima M; Hagiwara K; Bennett WP; Yokota J; Harris CC
    Oncogene; 1997 Mar; 14(10):1255-8. PubMed ID: 9121777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis.
    Wu MS; Lee CW; Sheu JC; Shun CT; Wang HP; Hong RL; Lee WJ; Lin JT
    Hepatogastroenterology; 2002; 49(43):285-9. PubMed ID: 11941977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival.
    Falchetti M; Saieva C; Lupi R; Masala G; Rizzolo P; Zanna I; Ceccarelli K; Sera F; Mariani-Costantini R; Nesi G; Palli D; Ottini L
    Hum Pathol; 2008 Jun; 39(6):925-32. PubMed ID: 18440592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer.
    Garrigue-Antar L; Souza RF; Vellucci VF; Meltzer SJ; Reiss M
    Lab Invest; 1996 Aug; 75(2):263-72. PubMed ID: 8765326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII.
    Barrett JM; Rovedo MA; Tajuddin AM; Jilling T; Macoska JA; MacDonald J; Mangold KA; Kaul KL
    Prostate; 2006 May; 66(6):632-50. PubMed ID: 16388503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.
    Baker K; Raut P; Jass JR
    J Pathol; 2007 Nov; 213(3):257-65. PubMed ID: 17893910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
    Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
    Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
    Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic progression in sporadic endometrial and gastrointestinal cancers with high microsatellite instability.
    Furlan D; Casati B; Cerutti R; Facco C; Terracciano L; Capella C; Chiaravalli AM
    J Pathol; 2002 Aug; 197(5):603-9. PubMed ID: 12210079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes.
    Oliveira C; Seruca R; Seixas M; Sobrinho-Simões M
    Am J Pathol; 1998 Oct; 153(4):1211-9. PubMed ID: 9777952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogenic expression of TGFbeta 1, 2, and 3 and its receptors in the rat gastric mucosa.
    de Andrade Sá ER; Jordão LR; Takahashi CA; Alvares EP; Gama P
    Dev Dyn; 2003 Jul; 227(3):450-7. PubMed ID: 12815632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.
    Hempen PM; Zhang L; Bansal RK; Iacobuzio-Donahue CA; Murphy KM; Maitra A; Vogelstein B; Whitehead RH; Markowitz SD; Willson JK; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 2003 Mar; 63(5):994-9. PubMed ID: 12615714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M; Ihn H; Yamane K; Tamaki K
    Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.